SGLT2-inhibitors on PC-AKI

Clinical trial NCT06491953 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06491953
Sponsor: Shenyang Northern Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy

Start date: 2024-06-01
Primary completion: 2025-05-30
Enrollment: 3600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.